Updates in the Management of Non-Muscle Invasive Bladder Cancer
Advertisement
Advertisement
Trending on Urology Times
1
Darolutamide associated with less cognitive change than enzalutamide in prostate cancer
2
ESMO 2026: Key presentations across genitourinary oncology
3
KLK2-comPAS trial explores dual T-cell engagement in mCRPC
4
Adding perioperative pembrolizumab to chemotherapy does not improve EFS in MIBC
5